UnitedHealth Group (NYSE:UNH) Sets New 1-Year High Following Strong Earnings

UnitedHealth Group Incorporated (NYSE:UNH)’s share price reached a new 52-week high on Thursday after the company announced better than expected quarterly earnings. The company traded as high as $433.48 and last traded at $425.08, with a volume of 75815 shares traded. The stock had previously closed at $403.55.

The healthcare conglomerate reported $4.52 EPS for the quarter, beating analysts’ consensus estimates of $4.41 by $0.11. The firm had revenue of $72.34 billion for the quarter, compared to analysts’ expectations of $71.24 billion. UnitedHealth Group had a return on equity of 22.15% and a net margin of 5.33%. The business’s revenue for the quarter was up 11.1% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $3.51 EPS.

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 21st. Stockholders of record on Monday, September 13th were paid a $1.45 dividend. This represents a $5.80 dividend on an annualized basis and a dividend yield of 1.37%. The ex-dividend date of this dividend was Friday, September 10th. UnitedHealth Group’s payout ratio is presently 34.36%.

UNH has been the subject of several research analyst reports. Truist Securities lifted their price objective on UnitedHealth Group from $480.00 to $500.00 and gave the stock a “buy” rating in a report on Friday, July 16th. Morgan Stanley reduced their price objective on UnitedHealth Group from $515.00 to $488.00 and set an “overweight” rating on the stock in a research note on Tuesday, August 31st. Seaport Res Ptn reiterated a “buy” rating on shares of UnitedHealth Group in a report on Friday, July 9th. Truist upped their target price on UnitedHealth Group from $480.00 to $500.00 and gave the stock a “buy” rating in a report on Friday, July 16th. Finally, Credit Suisse Group upped their target price on UnitedHealth Group from $430.00 to $462.00 and gave the company an “outperform” rating in a research report on Friday, July 16th. Three analysts have rated the stock with a hold rating, twenty have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, UnitedHealth Group has an average rating of “Buy” and a consensus target price of $447.79.

In other UnitedHealth Group news, Director Stephen J. Hemsley sold 60,000 shares of UnitedHealth Group stock in a transaction dated Friday, July 16th. The stock was sold at an average price of $420.62, for a total value of $25,237,200.00. Following the transaction, the director now owns 941,560 shares in the company, valued at $396,038,967.20. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Richard T. Burke sold 8,000 shares of UnitedHealth Group stock in a transaction that occurred on Tuesday, July 20th. The stock was sold at an average price of $414.31, for a total value of $3,314,480.00. Following the completion of the transaction, the director now directly owns 154,403 shares in the company, valued at $63,970,706.93. The disclosure for this sale can be found here. In the last three months, insiders sold 101,438 shares of company stock valued at $42,396,929. 0.55% of the stock is currently owned by insiders.

A number of institutional investors and hedge funds have recently modified their holdings of UNH. SignalPoint Asset Management LLC lifted its position in shares of UnitedHealth Group by 3.1% in the second quarter. SignalPoint Asset Management LLC now owns 786 shares of the healthcare conglomerate’s stock worth $315,000 after buying an additional 24 shares in the last quarter. Davis Rea LTD. lifted its holdings in UnitedHealth Group by 0.4% during the second quarter. Davis Rea LTD. now owns 6,782 shares of the healthcare conglomerate’s stock worth $2,716,000 after buying an additional 25 shares during the period. Tandem Capital Management Corp ADV lifted its holdings in shares of UnitedHealth Group by 0.9% during the 2nd quarter. Tandem Capital Management Corp ADV now owns 2,693 shares of the healthcare conglomerate’s stock valued at $1,078,000 after purchasing an additional 25 shares during the last quarter. Foster Group Inc. lifted its holdings in shares of UnitedHealth Group by 1.0% during the 2nd quarter. Foster Group Inc. now owns 2,466 shares of the healthcare conglomerate’s stock valued at $987,000 after purchasing an additional 25 shares during the last quarter. Finally, Waters Parkerson & CO. LLC increased its position in shares of UnitedHealth Group by 3.2% in the 2nd quarter. Waters Parkerson & CO. LLC now owns 807 shares of the healthcare conglomerate’s stock valued at $323,000 after acquiring an additional 25 shares during the period. 86.21% of the stock is currently owned by institutional investors and hedge funds.

The company has a current ratio of 0.77, a quick ratio of 0.77 and a debt-to-equity ratio of 0.62. The stock has a market capitalization of $399.32 billion, a price-to-earnings ratio of 26.65, a PEG ratio of 1.62 and a beta of 0.77. The stock has a 50-day moving average price of $411.69 and a 200 day moving average price of $405.33.

UnitedHealth Group Company Profile (NYSE:UNH)

UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.

Recommended Story: Options Trading – What is a Straddle?

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.